© 2020 MJH Life Sciences and Drug Topics. All rights reserved.
June 13, 2020
Presented during ADA’s 80th Scientific Sessions, results from an analysis of a 6-month telehealth intervention showed sustained improvements in glycemic control in patients with diabetes.
June 12, 2020
An analysis focused on patients with type 2 diabetes in rural regions, where accessibility to physicians is often limited.
June 08, 2020
Pharmacists must be tuned in to the latest technology for patients who monitor blood glucose.
June 03, 2020
Carla Cox, PhD, registered dietician and certified diabetes educator, discusses key information about COVID-19 that individuals with diabetes should know.
June 01, 2020
This is the first regulatory approval for aspirin plus ticagrelor dual antiplatelet therapy for individuals with high cardiovascular risk but without prior instances of heart attack or stroke.
May 29, 2020
Apotex Corp is voluntarily recalling all lots of metformin hydrochloride extended-release tablets, USP 500 mg, within expiry to retail level.
CMS is reducing insulin copays for seniors who are eligible for Medicare via an executive order from President Donald Trump.
May 28, 2020
Months after FDA said it was investigating the carcinogenic ingredient NDMA in metformin products, the agency’s testing has found elevated levels of NDMA in extended release metformin, but not in the immediate release formulation.
May 07, 2020
A new study suggests that well-controlled blood sugar may reduce mortality for patients with diabetes and COVID-19.
May 04, 2020
A new study evaluated methods of improving heart function in individuals with type 2 diabetes.